Periodic Reporting for period 1 - ProstaPalp (Feasibility study to evaluate a novel prostate cancer diagnostic)

Current screening for prostate cancer involves a prostate-specific antigen (PSA) test followed by a digital rectal examination (DRE) where a clinician feels for lumps on the prostate gland using their index finger. A high PSA result will typically lead to tissue samples...